Clinical Trial: A multicenter, randomized, phase III clinical trial of roprostim N01 combined with high-dose dexamethasone and intravenous immunoglobulin in the treatment of newly diagnosed severe ITP (China)

China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter, randomized, phase III clinical trial of roprostim N01 combined with high-dose dexamethasone and intravenous immunoglobulin in the treatment of newly diagnosed severe ITP'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134746

Registration Time: 2026/10/20

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Nanchang University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=346469

Published by HT Digital Content Services with permission from Health Daily Digest....